Clinical Trials Browser

Phase 1/2 × Advanced or Metastatic Solid Tumors × fludarabine × Clear all

NCT05693844 2024-05-10

Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced or Metastatic Solid Tumors